Liver Regeneration
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Updated: Jun 15, 2025
Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
Published on: December 2, 2022
Wei Wong1
1Science Signaling, AAAS, Washington, DC 20005, USA.
缺乏PKD1基因的体细胞可以预防脂肪肝疾病. 这种基因改造阻止了肝脏脂肪的积累,而不会导致瘤的形成.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论:
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015